 |
| Opinion | Top |
 |
 |
 |
| Editorials |
 |
 |
 |
Creating and shaping the marketplace? p597 doi:10.1038/nbt0797-597a PDF
(141K)
|
 |
 |
 |
Chickens, cows, bulls, and bears p597 doi:10.1038/nbt0797-597b PDF
(141K)
|
 |
 |
 |
| Commentary |
 |
 |
 |
Research Funding: Clinical investigators: The driving force behind drug discovery pp598 - 599 Jordan U. Gutterman doi:10.1038/nbt0797-598 References | PDF
(276K)
|
 |
 |
 |
US Federal Legislation: Clinton's cloning ban may threaten genetic research p600 Russ Hoyle doi:10.1038/nbt0797-600 PDF
(148K)
|
 |
| In Brief | Top |
 |
 |
 |
| Business and Regulatory News |
 |
 |
 |
Business & Regulatory News pp601 - 602 doi:10.1038/nbt0797-601 PDF
(717K)
|
 |
 |
 |
| Research News |
 |
 |
 |
Research News p604 doi:10.1038/nbt0797-604 PDF
(279K)
|
 |
 |
 |
| This Month in Biotechnology |
 |
 |
 |
This Month In Nature Biotechnology p605 doi:10.1038/nbt0797-605 PDF
(334K)
|
 |
| Analysis | Top |
 |
 |
 |
| Business and Regulatory News |
 |
 |
 |
Roche−Mannheim: Cornering the diagnosis-led healthcare market pp607 - 608 Vicki Brower doi:10.1038/nbt0797-607 PDF
(636K)
|
 |
 |
 |
Bavarian concerns about BM takeover p608 Ingeborg Fürst doi:10.1038/nbt0797-608 PDF
(417K)
|
 |
 |
 |
US bioethicists say continue human cloning moratorium p609 Jeffrey L. Fox doi:10.1038/nbt0797-609a PDF
(145K)
|
 |
 |
 |
Europe/Japan face up to legal hurdles to cloning pp609 - 610 Adam Michael doi:10.1038/nbt0797-609b PDF
(337K)
|
 |
 |
 |
Biotech unruffled by setbacks pp610 - 611 Vicki Glaser doi:10.1038/nbt0797-610 PDF
(400K)
|
 |
 |
 |
"DARPAesque" risk in biological warfare programs pp611 - 612 Jeffrey L. Fox doi:10.1038/nbt0797-611 PDF
(331K)
|
 |
 |
 |
US military takes up phytoremediation p612 Jeffrey L. Fox doi:10.1038/nbt0797-612a PDF
(141K)
|
 |
 |
 |
Hemispherx: 300 patents, 20 staff pp612 - 613 Ken Chahine doi:10.1038/nbt0797-612b PDF
(275K)
|
 |
 |
 |
India fears patent and ethics abuses p613 Udo Schuklenk doi:10.1038/nbt0797-613 PDF
(151K)
|
 |
 |
 |
Millennium exploits retained right with new venture p614 Emma Dorey doi:10.1038/nbt0797-614 PDF
(193K)
|
 |
 |
 |
MRA agreement signals start of global harmonization p615 John Hodgson doi:10.1038/nbt0797-615 PDF
(186K)
|
 |
 |
 |
| Research News |
 |
 |
 |
Antibodies live long and prosper p617 Lutz Riechmann
& Philipp Holliger doi:10.1038/nbt0797-617 References | PDF
(164K)
|
 |
 |
 |
Happy coupling: Recruiting both antigen and effector function pp618 - 619 Douglas Fearon doi:10.1038/nbt0797-618 References | PDF
(273K)
|
 |
 |
 |
Accessories for naked DNA vaccines pp619 - 620 Hyam I. Levitsky doi:10.1038/nbt0797-619 References | PDF
(268K)
|
 |
 |
 |
Liposomal gene delivery: A complex package pp620 - 621 Leaf Huang
& Song Li doi:10.1038/nbt0797-620 References | PDF
(338K)
|
 |
 |
 |
Surface warfare against pathogens using mucosal vaccines pp622 - 623 John D. Clements doi:10.1038/nbt0797-622 References | PDF
(347K)
|
 |
 |
 |
Entering the domain of neurotrophin binding pp623 - 624 Barbara L. Hempstead
& Moses V. Chao doi:10.1038/nbt0797-623 References | PDF
(275K)
|
 |
 |
 |
Evolution goes for GOLD in silico p624 Clare Sansom doi:10.1038/nbt0797-624 PDF
(152K)
|
 |
| Feature | Top |
 |
 |
 |
Molecular technologies for biodiversity evaluation: Opportunities and challenges pp625 - 628 Angela Karp, Keith J. Edwards, Mike Bruford, Stephan Funk, Ben Vosman, Michele Morgante, Ole Seberg, Antoine Kremer, Pierre Boursot, Peter Arctander, Diethard Tautz
& Godfrey M. Hewitt doi:10.1038/nbt0797-625 Abstract + references | PDF
(962K)
|
 |
| Research Articles | Top |
 |
 |
 |
Complement recruitment using bispecific diabodies pp629 - 631 Roland E. Kontermann, Mark G. Wing
& Greg Winter doi:10.1038/nbt0797-629 Abstract + references | PDF
(471K)
|
 |
 |
 |
Retargeting serum immunoglobulin with bispecific diabodies pp632 - 636 Philipp Holliger, Mark Wing, John D. Pound, Heribert Bohlen
& Greg Winter doi:10.1038/nbt0797-632 Abstract + references | PDF
(735K)
|
 |
 |
 |
Increasing the serum persistence of an IgG fragment by random mutagenesis pp637 - 640 Victor Ghetie, Serguei Popov, Jozef Borvak, Caius Radu, Diana Matesoi, Corneliu Medesan, Raimund J. Ober
& E. Sally Ward doi:10.1038/nbt0797-637 Abstract + references | PDF
(557K)
|
 |
 |
 |
Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes pp641 - 646 Jong J. Kirn, Mark L. Bagarazzi, Neil Trivedi, Yin Hu, Ken Kazahaya, Darren M. Wilson, Richard Ciccarelli, Michael A. Chattergoon, Kesan Dang, Sundarasamy Mahalingam, Ara A. Chalian, Michael G. Agadjanyan, Jean D. Boyer, Bin Wang
& David B. Weiner doi:10.1038/nbt0797-641 Abstract + references | PDF
(820K)
|
 |
 |
 |
Improved DNA: liposome complexes for increased systemic delivery and gene expression pp647 - 652 Nancy Smyth Templeton, Danilo D. Lasic, Peter M. Frederik, Helmut H. Strey, David D. Roberts
& George N. Pavlakis doi:10.1038/nbt0797-647 Abstract + references | PDF
(905K)
|
 |
 |
 |
Oral vaccination of mice against tetanus with recombinant Lactococcus lactis pp653 - 657 Karen Robinson, Lisa M. Chamberlain, Karin M. Schofield, Jeremy M. Wells
& Richard W.F. Le Page doi:10.1038/nbt0797-653 Abstract + references | PDF
(939K)
|
 |
 |
 |
Structure-based design and protein engineering of intersubunit disulfide bonds in gonadotropins pp658 - 662 Judith C. Heikoop, Paul van den Boogaart, John WM Mulders
& Peter D.J. Grootenhuis doi:10.1038/nbt0797-658 Abstract + references | PDF
(664K)
|
 |
 |
 |
Design of stable biologically active recombinant lutropin analogs pp663 - 667 Vicenta Garcia-Campayo, Asomi Sato, Burkhard Hirsch, Tadashi Sugahara, Mesut Muyan, Aaron J.W. Hsueh
& Irving Boime doi:10.1038/nbt0797-663 Abstract + references | PDF
(618K)
|
 |
 |
 |
Immunoglobulin-like domains define the nerve growth factor binding site of the TrkA receptor pp668 - 672 Paul H. Holden, Vipin Asopa, Alan G.S. Robertson, Anthony R. Clarke, Sue Tyler, Gavin S. Bennett, Susan D. Brain, Gordon K. Wilcock, Shelley J. Allen, Stephanie K.F. Smith
& David Dawbarn doi:10.1038/nbt0797-668 Abstract + references | PDF
(663K)
|
 |
 |
 |
Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV pp673 - 677 Daniel J. Drucker, Qing Shi, Anna Crivici, Martin Sumner-Smith, Wendy Tavares, Mary Hill, Lorraine DeForest, Sari Cooper
& Patricia L. Brubaker doi:10.1038/nbt0797-673 Abstract + references | PDF
(657K)
|
 |
| Resources | Top |
 |
 |
 |
| Patents |
 |
 |
 |
Combining legal and business strategies to develop combinatorial chemistry businesses pp679 - 681 David Abraham doi:10.1038/nbt0797-679 Abstract | PDF
(656K)
|
 |
 |
 |
Patents applications in the area of combinational chemistry p682 doi:10.1038/nbt0797-682 PDF
(298K)
|
 |
 |
 |
| WWW Guide |
 |
 |
 |
Steps to building the virtual laboratory pp683 - 684 Randy S. Haun doi:10.1038/nbt0797-683 Abstract + references | PDF
(964K)
|
 |
 |
 |
| New Products |
 |
 |
 |
Looking at thermocyclers pp685 - 687 Riku Lähteenmdki
& John Hodgson doi:10.1038/nbt0797-685 Abstract | PDF
(744K)
|
 |
 |
 |
New Products p688 doi:10.1038/nbt0797-688 PDF
(172K)
|
 |
 |
 |
| Industry Trends |
 |
 |
 |
Critical issues in gene therapy commercialization pp689 - 690 Aris Persidis
& Michael S. Tomczyk doi:10.1038/nbt0797-689 Abstract | PDF
(310K)
|
 |
 |
 |
| People |
 |
 |
 |
People p691 doi:10.1038/nbt0797-691 PDF
(133K)
|
 |
Top |
 |
 |